logo
logo
Sign in

Growth Accelerated by Rising Prevalence of Monkeypox Infections, The global Monkeypox Treatment Market to Witness Increasing Growth

avatar
naufan
Growth Accelerated by Rising Prevalence of Monkeypox Infections, The global Monkeypox Treatment Market to Witness Increasing Growth

Monkeypox infections have been on the rise worldwide in the recent past. Monkeypox treatment aims to alleviate symptoms such as fever, chills, rash and fatigue, while the body's immune system fights the viral infection. Smallpox vaccines, antivirals and vaccine for monkeypox are commonly utilized as treatment options.

The global Monkeypox Treatment Market is estimated to be valued at US$ 82.86 Mn in 2023 and is expected to exhibit a CAGR of 17% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The rising prevalence of monkeypox infections across different parts of the world has significantly accelerated the demand for monkeypox treatment options over the recent past. According to some reports, monkeypox infections have been recorded in over 80 countries as on date. Growing incidence of international travel and spread of the virus to newer regions has contributed to the escalating cases. This has resulted in increased focus on development of more effective vaccines and therapeutics to enable safe and comprehensive monkeypox treatment. Leading medical agencies have also raised awareness regarding symptoms and preventive measures, which is further propelling the monkeypox treatment market growth.

Segment Analysis

Monkeypox Treatment market is segmented by treatment type into vaccines and antiviral drugs. The vaccines segment currently dominates the market owing to increasing vaccination drives around the world. Vaccines help prevent the spread of the virus and are thus in higher demand. Antiviral drugs segment is expected to witness growth during the forecast period supported by development of effective drugs to treat infected patients.

Key Takeaways

The Global Monkeypox Treatment Market Size is expected to witness high growth during the forecast period of 2023 to 2030 supported by rising cases worldwide.

Regional analysis: North America is currently the dominant region in the global market backed by higher awareness levels and easy access to treatment options such as vaccines. Europe is also a major market supported by rising government focus on developing effective countermeasures. However, Asia Pacific is expected to witness fastest growth during the forecast period owing to improving healthcare infrastructure and increasing initiatives to curb the spread of the disease in densely populated countries such as India and China.

Key players: Key players operating in the Monkeypox Treatment market are SIGA Technologies Inc., Chimerix, Inc., Bavarian Nordic, Sanofi SA., Emcure Pharma, Jinan Jinda Pharmaceutical Chemistry Co., Ltd. SIGA Technologies Inc. currently dominates the vaccines segment with its smallpox vaccine, JYNNEOS, approved for prevention of monkeypox disease. Chimerix, Inc. has an approved antiviral drug called Tembexa or Brincidofovir to treat smallpox.


Get more insights on this topic:

https://www.dailyprbulletin.com/monkeypox-treatment-market-size-foercast/  

collect
0
avatar
naufan
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more